Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene plus medroxyprogesterone versus medroxyprogesterone minimal stimulation in poor ovarian responders
ChiCTR-IPR-15006430Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of medroxyprogesterone acetate and clomiphene in infertility and poor ovarian response (POR) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Number of oocytes retrieved. Started May 2015; status: recruiting.
02
Drugs
medroxyprogesterone acetateclomiphene
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR-IPR-15006430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006430.